Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Tonon

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Oncoimmunology|July 9, 2015
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survivalGiulia Di Lullo, Magda Marcatti, Silvia Heltai, et al.
Oncotarget|August 26, 2015
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasiasMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
Journal of Materials Chemistry. B|March 26, 2024
Synergistic applications of cyclodextrin-based systems and metal-organic frameworks in transdermal drug delivery for skin cancer therapyThomas Scattolin, Giovanni Tonon, Eleonora Botter, et al.
Scientific Reports|January 16, 2023
RNA sequencing of blood from sex- and age-matched discordant siblings supports immune and transcriptional dysregulation in autism spectrum disorderPasquale Tomaiuolo, Ignazio Stefano Piras, Simona Baghai Sain, et al.
Haematologica|January 13, 2018
Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironmentDaniela Belloni, Silvia Heltai, Maurilio Ponzoni, et al.
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
The EMBO Journal|October 31, 2018
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolusMarco Gaviraghi, Claudia Vivori, Yerma Pareja Sanchez, et al.
Haematologica|October 15, 2020
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapiesOronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaKlaus Podar, Giovanni Tonon, Martin Sattler, et al.
Dalton Transactions (Cambridge, England : 2003)|April 30, 2024
Unveiling the promising anticancer activity of palladium(II)-aryl complexes bearing diphosphine ligands: a structure-activity relationship analysisGiovanni Tonon, Matteo Mauceri, Enrico Cavarzerani, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Oncoimmunology|July 9, 2015
Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survivalGiulia Di Lullo, Magda Marcatti, Silvia Heltai, et al.
Oncotarget|August 26, 2015
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasiasMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
Journal of Materials Chemistry. B|March 26, 2024
Synergistic applications of cyclodextrin-based systems and metal-organic frameworks in transdermal drug delivery for skin cancer therapyThomas Scattolin, Giovanni Tonon, Eleonora Botter, et al.
Scientific Reports|January 16, 2023
RNA sequencing of blood from sex- and age-matched discordant siblings supports immune and transcriptional dysregulation in autism spectrum disorderPasquale Tomaiuolo, Ignazio Stefano Piras, Simona Baghai Sain, et al.
Haematologica|January 13, 2018
Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironmentDaniela Belloni, Silvia Heltai, Maurilio Ponzoni, et al.
Cancer Letters|October 15, 2013
Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulationFengjuan Fan, Giovanni Tonon, Muhammad Hasan Bashari, et al.
The EMBO Journal|October 31, 2018
Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolusMarco Gaviraghi, Claudia Vivori, Yerma Pareja Sanchez, et al.
Haematologica|October 15, 2020
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapiesOronza A Botrugno, Silvia Bianchessi, Desirée Zambroni, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaKlaus Podar, Giovanni Tonon, Martin Sattler, et al.
Dalton Transactions (Cambridge, England : 2003)|April 30, 2024
Unveiling the promising anticancer activity of palladium(II)-aryl complexes bearing diphosphine ligands: a structure-activity relationship analysisGiovanni Tonon, Matteo Mauceri, Enrico Cavarzerani, et al.
Pageof 13